CSIMarket


Albireo Pharma inc   (ALBO)
Other Ticker:  
 


 

Albireo Pharma inc

ALBO's Financial Statements and Analysis



Albireo Pharma inc reported in the third quarter of 2022 net loss per share of $-1.92 compare to earnings per share of $2.90 in the same quarter a year ago and improved compare to net loss per share of $-2.04 realized in previous quarter.


third quarter of 2022
Earnings Per Share Revenues
$ -1.92 $  10 Mill
$-4.82     $+6M     +168.34 %



Albireo Pharma Inc 's Revenue rose by 168.34 % in third quarter of 2022 (Sep 30 2022) year on year, to $10 million and advanced by 19.81 % sequentially.


Albireo Pharma Inc is

More on ALBO's Income Statement



Albireo Pharma Inc 's in thethird quarter of 2022 recorded net loss of $-37.800 million, compare to net income of $57.086 million achieved in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-39.949 million realized in previous quarter.

More on ALBO's Growth

Albireo Pharma Inc Inventories
Inventories grew by 1506.63 % to $3 million from III. Quarter a year ago, sequentially inventories rose by 50.24 %. ALBO's Cash flow In the third quarter of 2022 company's net cash flow was $92 million, capital expenditures grew by -0.186-78.49%, to $0 millions compare to same quarter a year ago

More on ALBO's Cash flow Statement


Albireo Pharma inc does not pay out common stock dividend.

In trailing twelve-month period Albireo Pharma inc payed $ -5.87 cash per share, on a free-cash flow basis .

Book value fell by -12.28 % sequentially to $5.09 per share, -10.61% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 4.21 per share from $ 4.92.

Company issued 0.07 million shares or 0.36 % in Sep 30 2022.


More on ALBO's Dividends

 Market Capitalization (Millions) 868
 Shares Outstanding (Millions) 20
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 57
 Net Income (TTM) (Millions $) -131
 Cash Flow (TTM) (Millions $) 10
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Albireo Pharma inc does not pay out common stock dividend.

In trailing twelve-month period Albireo Pharma inc had negative $ -5.87 cash flow per share, on a free-cash flow basis .

Book value fell by -12.28 % sequentially to $5.09 per share, -10.61% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 4.21 per share from $ 4.92.

Company issued 0.07 million shares or 0.36 % in Sep 30 2022.


More on ALBO's Balance Sheets

 Market Capitalization (Millions) 868
 Shares Outstanding (Millions) 20
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 57
 Net Income (TTM) (Millions $) -131
 Cash Flow (TTM) (Millions $) 10
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   



Date modified: 2023-03-22T01:06:46+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com